About us
Services & Solutions
Chemistry Drug Metabolism and Pharmacokinetics (DMPK) Discovery Biology Oncology Pharmacology Biologics
Medicinal Chemistry Parallel Synthesis Peptide Chemistry Computational Chemistry Synthetic Chemistry Analytical Chemistry Scale Up Chemistry
In Vivo PK and TK In Vitro ADME Bioanalytical Service Exploratory Toxicity In Rodents, Dogs and Monkeys Large Molecules Capabilities Bioanalytical Instruments
Fragment Based Drug Discovery (FBDD) Biochemical Assays Cellular Assays Protein Science Assay Technologies Biophysics SPR Safety Pharmacology Screening Services Key Instruments
PDX CDX Orthotopic Models Syngeneic Models Humanized Mouse Models CAR-T and CAR-NK Mouse Models In Vitro Assays
Immunology Inflammation Metabolic NASH/MASH Respiratory Neuroscience
Systematic Antibody Discovery Service
Process R&D Scale Up Synthesis DS Manufacturing
Flow Chemistry Sugar Chemistry Peptide Chemistry Preparative Purification Capacity Process Safety Assessment
Synthetic and Scale Up Chemistry
Kilo and Pilot Scale Production RSM and Intermediates Manufacturing QA EHS
Preformulation Formulation, Analytical, and Process Development Drug Product Manufacturing
Bioavailability Enhancement Modified Release
Commercial Manufacturing
Platforms
News & Resources
Careers
Contact us
×

news

Company News Events Insights Webinars Virtual Tours

BioDuro Launches New Antibody & Cell Therapy Discovery Services

BioDuro launches new antibody and cell therapy discovery services, enhancing biologics development with advanced technologies and validated clinical pathways.
November 20, 2019

BioDuro Welcomes New Chief Financial Officer

Jeffery Blazevich joins BioDuro as CFO, bringing 30+ years of experience in technology, healthcare, and medical devices. His leadership will drive growth and
June 30, 2019

Congratulations to Sinovent for NMPA IND approval

Sinovent achieves NMPA IND approval for XNW7201, an innovative Wnt pathway inhibitor for digestive system tumors, supported by Sundia's comprehensive CRO services.
May 24, 2019

Session conference—BioKorea

Join Sundia at BioKorea for a session with industry leaders from Oscotec, Bridge Biotherapeutics, and U-Chem on accelerating IND filings through CRO partnerships
April 18, 2019

BioDuro partners with Advent International

BioDuro partners with Advent International to accelerate growth in global drug discovery, development, and manufacturing services. Moving you Forward.
January 15, 2019
Total 88 12...9101112131415...1718
Subscribe to BioDuro-Sundia
Receive our newsletter and information on upcoming events
Your trusted partner from drug discovery and
development to commercialization

Home

About us

Services & Solutions

Platforms

News & Resources

Careers

Contact us

Explore

Discovery

Drug Substance

Drug Product

© 2023 BioDuro-Sundia. All rights reserved
Terms of Use Privacy Policy
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all